Interface Biologics Announces $7M Financing (press release)
nterface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce the completion of a $7M series B financing, led by Business Development Bank of Canada in conjunction with Covington Capital and VG Partners.
...
Your friends are reading OrthoStreams daily - Are you ?
Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.
The Orthopedics Industry 
